Cargando…
Activity of high-dose cis-platinum (NCI 119875) in combination with vincristine and methotrexate in drug-resistant gestational choriocarcinoma. A report of 17 cases.
Autores principales: | Newlands, E. S., Bagshawe, K. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1979
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010146/ https://www.ncbi.nlm.nih.gov/pubmed/575049 |
Ejemplares similares
-
Phase I-II study of carboplatin vincristine methotrexate and bleomycin (COMB) in carcinoma of the cervix.
por: Rustin, G. J., et al.
Publicado: (1988) -
Mechanism of Methotrexate‐sensitivity of Choriocarcinoma Cells in Culture
por: Indue, Takami, et al.
Publicado: (1988) -
International symposium on gestational trophoblastic tumours: 23, 24 May 1979, Charing Cross Hospital, London
por: Newlands, E. S., et al.
Publicado: (1980) -
Comparison of the effects of the oral anticancer platinum(IV) complexes oxoplatin and metabolite cis-diammine-tetrachlorido-platinum(IV) on global gene expression of NCI-H526 cells
por: Olszewski, Ulrike, et al.
Publicado: (2011) -
Transcriptomic Characterization of Postmolar Gestational Choriocarcinoma
por: Collet, Constance, et al.
Publicado: (2021)